Supernus Pharmaceuticals, Inc. (SUPN)

USD 35.46

(-2.1%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.4 Billion 1.7 Billion 1.68 Billion 1.5 Billion 1.16 Billion 977.81 Million
Total Current Assets 493.11 Million 734.15 Million 601.59 Million 630.41 Million 472.64 Million 493.48 Million
Cash And Short Term Investments 254.87 Million 461.33 Million 339.68 Million 422.53 Million 347.07 Million 356.01 Million
Cash and Cash Equivalents 75.05 Million 93.12 Million 203.43 Million 288.64 Million 181.38 Million 192.24 Million
Short Term Investments 179.82 Million 368.21 Million 136.24 Million 133.89 Million 165.69 Million 163.77 Million
Net Receivables 144.15 Million 165.49 Million 148.93 Million 140.87 Million 87.33 Million 102.92 Million
Inventory 77.4 Million 91.54 Million 85.95 Million 48.32 Million 26.62 Million 25.65 Million
Other Current Assets 16.67 Million 15.77 Million 27.01 Million 18.68 Million 11.61 Million 8.88 Million
Total Non-Current Assets 915.86 Million 968.35 Million 1.08 Billion 873.68 Million 687.63 Million 484.32 Million
Net PPE 42.52 Million 15.17 Million 16.95 Million 37.82 Million 38.34 Million 4.09 Million
Good Will And Intangible Assets 716.9 Million 819.48 Million 902.2 Million 442.25 Million 24.84 Million 31.36 Million
Good Will 117.01 Million 117.01 Million 117.51 Million 77.91 Million - -
Intangible Assets 599.88 Million 702.46 Million 784.69 Million 442.25 Million 24.84 Million 31.36 Million
Long-Term Investments 16.61 Million 93.89 Million 119.16 Million 350.35 Million 591.77 Million 418.79 Million
Tax Assets 131.3 Million 49.8 Million 85.35 Million 35.21 Million 32.06 Million 29.68 Million
Other Non Current Assets 8.51 Million -10 Million -36.12 Million 8.03 Million 615 Thousand 380 Thousand
Other Assets - - - - - -
Total Liabilities 487.46 Million 816.3 Million 873.3 Million 759.24 Million 564.85 Million 524.78 Million
Total Current Liabilities 290.19 Million 687.95 Million 315.37 Million 245.1 Million 160.58 Million 161.35 Million
Account Payables 1.96 Million 96.34 Million 117.68 Million 78.93 Million 10.14 Million 3.19 Million
Tax Payables - - - - 2.44 Million 12.37 Million
Short Term Debt 8.33 Million 401.96 Million 6.47 Million 3.76 Million 2.82 Million 2.18 Million
Deferred Revenue 1.00 49.8 Million 126.24 Million 122.43 Million 144.37 Million -2.18 Million
Other Current Liabilities 279.9 Million 139.83 Million 64.97 Million 39.98 Million 3.24 Million 158.15 Million
Total Non Current Liabilities 197.26 Million 128.34 Million 557.92 Million 514.13 Million 404.26 Million 363.43 Million
Long-Term Debt 33.19 Million 35.99 Million 420.55 Million 390.33 Million 375.61 Million 329.46 Million
Deferred Revenue Non Current - - - - -37.29 Million -31.46 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 7.8 Million 42.53 Million 52.01 Million 88.59 Million 28.65 Million 33.97 Million
Other Liabilities - - - - - -
Total Equity 921.51 Million 886.2 Million 815.85 Million 744.85 Million 595.42 Million 453.02 Million
Stock Holders Equity 921.51 Million 886.2 Million 815.85 Million 744.85 Million 595.42 Million 453.02 Million
Common Stock 55 Thousand 54 Thousand 53 Thousand 53 Thousand 53 Thousand 52 Thousand
Retained Earnings 482.56 Million 481.24 Million 379.92 Million 326.49 Million 199.54 Million 86.49 Million
Accumulated other comprehensive income -593 Thousand -3.21 Million 1.53 Million 8.97 Million 7.41 Million -3.15 Million
Common Stock Equity 921.51 Million 886.2 Million 815.85 Million 744.85 Million 595.42 Million 453.02 Million
Capital Lease Obligation 33.19 Million 35.99 Million 41.29 Million 28.57 Million 30.44 Million -
Total Investments 196.43 Million 462.11 Million 255.41 Million 484.25 Million 757.46 Million 582.56 Million
Total Debt 41.52 Million 437.96 Million 420.55 Million 390.33 Million 375.61 Million 329.46 Million
Net Debt -33.52 Million 344.84 Million 217.11 Million 101.69 Million 194.22 Million 137.21 Million

Balance Sheet Charts